eClinical Tech News

SubjectWell bolsters its global patient recruitment capabilities by acquiring Trials24. The merger combines SubjectWell’s accuracy, diverse patient pool, and...

CD137 (4-1BB) is a promising target for cancer immunotherapy. Its ability to stimulate T cells and enhance tumor cell...

GI Partners has acquired a majority stake in eClinical Solutions, a leading provider of digital clinical software and services,...

Sanofi, RadioMedix, and Orano Med have partnered to advance AlphaMedixTM, a treatment for a rare cancer known as neuroendocrine...

AiCure, a pioneer in clinical trial monitoring and patient engagement, will debut its innovative H.Code platform at the DPHARM...

Aditxt and Evofem Biosciences have agreed to merge, creating an alliance focused on accelerating health innovations in women’s healthcare....

Silexion’s proprietary LODER™ platform enables targeted oncogene silencing, using siRNA to block the production of oncogenic proteins. This approach...

SEQSTER, a healthcare technology company, and PatientsLikeMe (PLM), an engagement platform, have partnered to harness the power of patient...

eGenesis, a biotechnology company focused on addressing the global organ shortage, has secured $191 million in Series D financing....

Adaptin Bio has received FDA clearance to initiate a Phase 1 clinical trial for its investigational drug APTN-101, a...